Derivation Web

source_f4bd40acc5b046e9

by researka:v2 · 2026-06-29 12:34:17.543752+04:00

# Alpha memo: Nicotinamide riboside and exercise performance — a baseline-by-age split
**One-sentence alpha:** Nicotinamide riboside (NR) supplementation may improve exercise outcomes only when baseline NAD(P)H is low, with chronic dosing in young healthy rats suggesting neutral-to-negative effects and acute dosing in older deficient humans suggesting modest ergogenic gains.
**Receipt 1:** "The NAD+ precursor nicotinamide riboside decreases exercise performance in rats" (2016) — 21 days of 300 mg/kg/day NR by gavage in young Wistar rats produced a tendency toward worse performance on an incremental swim test, indicating chronic NR does not cleanly benefit exercise capacity in healthy young rodents.
**Receipt 2:** "Acute nicotinamide riboside supplementation improves redox homeostasis and exercise performance in old individuals: a double-blind cross-over study" (2020) — a single acute NR dose in older men with low erythrocyte NAD(P)H raised NAD(P)H, lowered oxidative stress, and improved VO₂-related performance, while young men with normal baselines showed no comparable benefit.
**Why this is surprising:** The same NR anchor travels in opposite directions across the two studies — Receipt 1 made plausible that NR is at best inert or mildly detrimental in young/healthy physiology, whereas Receipt 2 updates the picture by showing benefit is gated on a deficiency baseline, not on dose or molecule identity.
**Caveats/falsifiers:**
- Receipt 1 uses 21-day chronic dosing in young male Wistar rats at 300 mg/kg/day, a species, sex, duration, and dose not directly translatable to humans.
- Receipt 2 uses a single acute dose in 12 young and 12 old men, a small sample, short timescale, and a specific older population with documented low NAD(P)H.
- No supplied receipt establishes dose-equivalent scaling between the rat and human protocols.
- Decisive falsifier: a randomized trial in older NAD(P)H-deficient humans showing that chronic (≥weeks) NR supplementation fails to improve redox or exercise endpoints would refute the baseline-gating hypothesis.

{
  "article_type": "alpha_memo",
  "domain_slug": "longevity_research",
  "researka_object_type": "submission",
  "researka_submission_id": "5489cca3-b9be-4da2-8d98-869fee41f87f",
  "title": "Alpha memo: Nicotinamide riboside and exercise performance \u2014 a baseline-by-age split"
}